adenosine has been researched along with Atheroma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Dong, X; Fu, J; Tu, Q; Wu, F; Xie, H; Xu, H | 1 |
| Ahmadi, A; Bom, MJ; Danad, I; Davies, JE; de Waard, GA; Driessen, RS; Knaapen, P; Knuuti, J; Leipsic, JA; Min, JK; Narula, J; Raijmakers, PG; Stuijfzand, WJ; van de Ven, PM; van Rossum, AC; van Royen, N | 1 |
| Gaudry, M; Guieu, R; Paganelli, F; Ruf, J | 1 |
| Abbas, A; Alseth, I; Aukrust, P; Bjørås, M; Dahl, TB; Gregersen, I; Halvorsen, B; Holm, S; Kong, XY; Mittelstedt Leal de Sousa, M; Quiles-Jiménez, A; Skagen, K; Skjelland, M | 1 |
| Bryniarski, K; Hou, J; Hu, S; Jang, IK; Jia, H; Lee, H; Li, L; Liu, H; Ma, L; Sugiyama, T; Wang, C; Xing, L; Xu, M; Yamamoto, E; Yu, B; Zhang, S; Zhu, Y | 1 |
| Jeong, LS; Jeong, SJ; Kim, G; Oh, GT; Park, JG; Yu, J | 1 |
| Choi, BJ; Choi, SY; Hwang, GS; Jin, XJ; Lim, HS; Park, JS; Shin, JH; Tahk, SJ; Yang, HM; Yoon, MH | 1 |
| Huang, W; Ling, W; Peng, C; Xia, M; Xiao, Y; Zhang, J | 1 |
| Ahmadi, N; Azen, S; Hajsadeghi, F; Hodis, H; Lerman, A; Mack, W; Ruiz-Garcia, J | 1 |
| Barton, R; Hove, JD; Kofoed, KF; Kühl, JT; Linde, JJ; Sørgaard, M; Thomsen, AF; Udholm, PM | 1 |
| Ahn, JM; Chang, M; Kang, SJ; Kim, YH; Lee, CW; Lee, HS; Lee, SW; Moon, DH; Oh, M; Park, DW; Park, SJ; Park, SW | 1 |
| Bea, F; Blessing, E; Katus, HA; Mogler, C; Preusch, MR; Rusnak, J; Sievers, P; Staudacher, I; Staudacher, K; Uhlmann, L | 1 |
1 review(s) available for adenosine and Atheroma
| Article | Year |
|---|---|
Recent advances in the role of the adenosinergic system in coronary artery disease.
Topics: Adenosine; Animals; Blood Platelets; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Humans; Plaque, Atherosclerotic; Purinergic Agents; Receptor, Adenosine A2A; Signal Transduction | 2021 |
2 trial(s) available for adenosine and Atheroma
| Article | Year |
|---|---|
Adverse Plaque Characteristics Relate More Strongly With Hyperemic Fractional Flow Reserve and Instantaneous Wave-Free Ratio Than With Resting Instantaneous Wave-Free Ratio.
Topics: Adenosine; Aged; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Male; Middle Aged; Multidetector Computed Tomography; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Vasodilator Agents | 2020 |
Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
Topics: Adenosine; Aged; Anti-Inflammatory Agents; Carotid Arteries; Carotid Stenosis; Clopidogrel; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Radiopharmaceuticals; Republic of Korea; Severity of Illness Index; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
9 other study(ies) available for adenosine and Atheroma
| Article | Year |
|---|---|
Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Glucosides; Inflammation; Lipoproteins, LDL; Macrophages; Mice; NF-kappa B; Plaque, Atherosclerotic; RNA; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis.
Topics: Adenosine; Carotid Artery Diseases; Chromatography, Liquid; Humans; Methylation; Methyltransferases; Oxidoreductases, N-Demethylating; Plaque, Atherosclerotic; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Ribosomal; Tandem Mass Spectrometry | 2020 |
EROSION Study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography-Based Management in Plaque Erosion): A 1-Year Follow-Up Report.
Topics: Acute Coronary Syndrome; Adenosine; Adult; Aspirin; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Disease-Free Survival; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Risk Factors; Thrombectomy; Ticagrelor; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2017 |
LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Apolipoproteins E; Atherosclerosis; Bile Acids and Salts; Biosynthetic Pathways; Diet, Western; Gene Expression Regulation; Hypercholesterolemia; Liver; Mice, Knockout; Plaque, Atherosclerotic; Receptor, Adenosine A3; Transcription Factors | 2018 |
Relationship between intravascular ultrasound parameters and fractional flow reserve in intermediate coronary artery stenosis of left anterior descending artery: intravascular ultrasound volumetric analysis.
Topics: Adenosine; Aged; Cardiac Catheterization; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Male; Middle Aged; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Severity of Illness Index; Ultrasonography, Interventional; Vasodilator Agents | 2014 |
Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Binding Sites; CCAAT-Enhancer-Binding Proteins; Cell Line; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Heat-Shock Proteins; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Male; Methylation; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; S-Adenosylhomocysteine; Time Factors; Up-Regulation | 2015 |
Impaired coronary artery distensibility is an endothelium-dependent process and is associated with vulnerable plaque composition.
Topics: Acetylcholine; Adenosine; Adult; Area Under Curve; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Endothelium, Vascular; Female; Humans; Infusions, Intra-Arterial; Injections, Intra-Arterial; Male; Microcirculation; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; ROC Curve; Severity of Illness Index; Ultrasonography, Interventional; Vasodilator Agents | 2016 |
Functional Impact of Atherosclerosis on Epicardial Coronary Conductance Vessels Assessed With MDCT.
Topics: Adenosine; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Humans; Multidetector Computed Tomography; Pericardium; Plaque, Atherosclerotic; Predictive Value of Tests; Severity of Illness Index; Vascular Calcification; Vasodilation; Vasodilator Agents | 2017 |
Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis.
Topics: Adenosine; Administration, Oral; Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Disease Models, Animal; Dose-Response Relationship, Drug; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Structure-Activity Relationship; Ticagrelor | 2016 |